Lonza Begins Tender Offer To Acquire Arch Chemicals

Biocides company Arch Chemicals announced that Lonza's subsidiary, Lonza LG Acquisition Corp., has commenced the previously announced offer to acquire all of the outstanding shares of common stock of Arch Chemicals at a price of $47.20 per share, net to the seller in cash, without interest and less any required withholding of taxes.

The tender offer is scheduled to expire on Aug. 11. The closing of the tender offer is subject to customary terms and conditions. On July 11, Lonza announced its intention to acquire Arch through a tender offer for $47.20 per share in cash. As per the deal, the germs control product maker's enterprise value would be $1.4 billion or about 1.25 billion Swiss francs.

 

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.